Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ritonavir 100mg tablets
0503010U0AAACAC
|
Ritonavir | Ritonavir | Infections | 3 |
|
Norvir 100mg capsules
0503010U0BBACAA
|
Norvir | Ritonavir | Infections | No data available |
|
Norvir 100mg oral powder sachets
0503010U0BBAEAD
|
Norvir | Ritonavir | Infections | No data available |
|
Norvir 100mg tablets
0503010U0BBADAC
|
Norvir | Ritonavir | Infections | No data available |
|
Norvir 80mg/ml oral solution
0503010U0BBABAB
|
Norvir | Ritonavir | Infections | No data available |
|
Ritonavir 100mg capsules
0503010U0AAAAAA
|
Ritonavir | Ritonavir | Infections | No data available |
|
Ritonavir 100mg oral powder sachets sugar free
0503010U0AAADAD
|
Ritonavir | Ritonavir | Infections | No data available |
|
Ritonavir 80mg/1ml oral solution sugar free
0503010U0AAABAB
|
Ritonavir | Ritonavir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.